AR036187A1 - Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario - Google Patents

Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario

Info

Publication number
AR036187A1
AR036187A1 ARP020102743A ARP020102743A AR036187A1 AR 036187 A1 AR036187 A1 AR 036187A1 AR P020102743 A ARP020102743 A AR P020102743A AR P020102743 A ARP020102743 A AR P020102743A AR 036187 A1 AR036187 A1 AR 036187A1
Authority
AR
Argentina
Prior art keywords
compound
alkyl
formula
intermediary
preparation
Prior art date
Application number
ARP020102743A
Other languages
English (en)
Spanish (es)
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8183486&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR036187(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Adir filed Critical Adir
Publication of AR036187A1 publication Critical patent/AR036187A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44Two oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
ARP020102743A 2001-07-24 2002-07-22 Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario AR036187A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01500197 2001-07-24

Publications (1)

Publication Number Publication Date
AR036187A1 true AR036187A1 (es) 2004-08-18

Family

ID=8183486

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020102743A AR036187A1 (es) 2001-07-24 2002-07-22 Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario

Country Status (23)

Country Link
US (1) US20040248814A1 (enExample)
EP (1) EP1279665B1 (enExample)
JP (1) JP4083118B2 (enExample)
KR (1) KR100694528B1 (enExample)
CN (1) CN100503568C (enExample)
AR (1) AR036187A1 (enExample)
AT (1) ATE386717T1 (enExample)
AU (1) AU2002328954B2 (enExample)
BR (1) BR0211422A (enExample)
CY (1) CY1107403T1 (enExample)
DE (1) DE60225092T2 (enExample)
DK (1) DK1279665T3 (enExample)
EA (1) EA007000B1 (enExample)
ES (1) ES2300402T3 (enExample)
HU (1) HUP0202414A3 (enExample)
MX (1) MXPA04000649A (enExample)
NO (1) NO20040278L (enExample)
NZ (1) NZ530578A (enExample)
PL (1) PL355161A1 (enExample)
PT (1) PT1279665E (enExample)
SI (1) SI1279665T1 (enExample)
WO (1) WO2003010142A2 (enExample)
ZA (1) ZA200400323B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1333026T1 (sl) 2002-01-30 2007-10-31 Servier Lab Postopek priprave perindoprila visoke äśistoäśe in intermediatov uporabnih v sintezi
JP4461027B2 (ja) 2003-02-28 2010-05-12 レ ラボラトワール セルヴィエ ペリンドプリルおよびその塩の製法
ES2320771T3 (es) 2003-04-16 2009-05-28 Bristol-Myers Squibb Company Inhibidores peptidicos de isoquinolina macrociclicos del virus de la hepatitis c.
SI21506A (sl) * 2003-05-08 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo perindoprila
SI21507A (sl) 2003-05-16 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo spojin z ace inhibitornim delovanjem
AU2003263584A1 (en) * 2003-08-21 2005-03-10 Hetero Drugs Limited Process for pure perindopril tert-butylamine salt
DK1675827T3 (da) * 2003-10-21 2010-04-19 Servier Lab Ny fremgangsmåde til fremstilling af krystallint perindopril erbumin
SI21703A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
ES2255872B1 (es) * 2004-12-31 2007-08-16 Quimica Sintetica, S.A. Procedimiento para la preparacion de perindopril erbumina.
US7291745B2 (en) 2005-03-21 2007-11-06 Glenmark Pharmaceuticals Limited Process for the preparation of perindopril
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
WO2006137082A1 (en) * 2005-06-23 2006-12-28 Ramesh Babu Potluri Process for industrially viable preparation of perindopril erbumine
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
EP2044010B1 (en) 2006-05-12 2014-01-08 EGIS Gyógyszergyár Nyilvánosan Müködõ Részvénytársaság New pharmaceutical intermediates in the synthesis of ace-inihibitors and the use thereof
JP2008019214A (ja) * 2006-07-13 2008-01-31 Shiono Chemical Co Ltd ペリンドプリルまたはその誘導体の製造方法
SI2150538T1 (sl) * 2007-06-06 2012-07-31 Dsm Sinochem Pharmaceuticals Nl B V Novi substituirani hidantoini
FR2985512B1 (fr) * 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
CN111116709B (zh) * 2019-12-31 2022-06-24 北京鑫开元医药科技有限公司 一种培哚普利制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2487829A2 (fr) * 1979-12-07 1982-02-05 Science Union & Cie Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
US4508729A (en) * 1979-12-07 1985-04-02 Adir Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
DE3174844D1 (en) * 1980-10-23 1986-07-24 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
ZA817261B (en) * 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
US4496542A (en) * 1981-03-30 1985-01-29 Usv Pharmaceutical Corporation N-substituted-amido-amino acids
US4558038A (en) * 1981-03-30 1985-12-10 Usv Pharmaceutical Corp. N-Substituted-amindo-amino acids
US4686295A (en) * 1982-03-10 1987-08-11 Usv Pharmaceutical Corporation N-carboxy anhydride intermediates
US4885293A (en) * 1984-09-24 1989-12-05 Schering Corporation Antiglaucoma agents
JPS6248696A (ja) * 1985-08-27 1987-03-03 Kanegafuchi Chem Ind Co Ltd N−〔1(s)−エトキシカルボニル−3−フエニルプロピル〕−l−アラニル−l−プロリンの製造法
ES2004804A6 (es) 1987-08-13 1989-02-01 Pharma Investi S A Un procedimiento para preparar derivados de carboxialquildipeptidos
FR2620699B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et de leurs esters. application a la synthese de carboxyalkyl dipeptides
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2620703B1 (fr) * 1987-09-17 1991-10-04 Adir Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides
FR2620700B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et leurs esters. application a la synthese de carboxyalkyl dipeptides
US5258525A (en) * 1991-03-27 1993-11-02 Mcneilab, Inc. Processes for preparing [2S-(2α,3aβ,7aβ)]octahydro-1H-indole-2-carboxylic acid and esters
SI9200213A (en) * 1992-09-16 1994-03-31 Krka Process for preparing alkyl-l-alanil-l-proline derivates
IN184759B (enExample) 1997-07-22 2000-09-23 Kaneka Corp
SE0000382D0 (sv) * 2000-02-07 2000-02-07 Astrazeneca Ab New process

Also Published As

Publication number Publication date
HUP0202414A3 (en) 2003-05-28
EA007000B1 (ru) 2006-06-30
HU0202414D0 (enExample) 2002-09-28
AU2002328954B2 (en) 2007-10-04
PT1279665E (pt) 2008-03-28
HUP0202414A2 (hu) 2003-02-28
EP1279665A3 (en) 2003-03-12
SI1279665T1 (sl) 2008-06-30
DE60225092D1 (de) 2008-04-03
CN100503568C (zh) 2009-06-24
NO20040278L (no) 2004-01-21
EP1279665A2 (en) 2003-01-29
HK1067129A1 (en) 2005-04-01
ZA200400323B (en) 2005-03-30
ATE386717T1 (de) 2008-03-15
KR100694528B1 (ko) 2007-03-13
WO2003010142A3 (en) 2003-08-28
PL355161A1 (en) 2003-01-13
ES2300402T3 (es) 2008-06-16
DK1279665T3 (da) 2008-06-23
DE60225092T2 (de) 2009-02-19
JP4083118B2 (ja) 2008-04-30
EP1279665B1 (en) 2008-02-20
KR20040029378A (ko) 2004-04-06
JP2005501829A (ja) 2005-01-20
CN1529694A (zh) 2004-09-15
MXPA04000649A (es) 2004-10-27
US20040248814A1 (en) 2004-12-09
CY1107403T1 (el) 2012-12-19
BR0211422A (pt) 2004-08-17
WO2003010142A2 (en) 2003-02-06
EA200400129A1 (ru) 2004-08-26
NZ530578A (en) 2007-02-23

Similar Documents

Publication Publication Date Title
AR036187A1 (es) Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
UA96314C2 (ru) Замещенные 1-(3-пиридинил)пиразол-4-илуксусные кислоты и их применение в качестве гербицидов и регуляторов роста растений
PE20040636A1 (es) Ester de 2'-c-metil-3'-o-l-valina de ribofuranosilcitidina
MY145460A (en) Biaryl ether urea compounds
BR0307432B1 (pt) difluormetiltiazolilcarboxanilidas
AR066972A1 (es) Derivados azapeptidicos
MX2010007679A (es) Compuestos herbicidas.
SG170729A1 (en) Processes and intermediates for preparing steric compounds
UA81567C2 (en) Heteroaroyl-substituted phenylalanine amides
AR084433A1 (es) Inhibidores de la faah y composiciones farmaceuticas que los contienen
GEP20074133B (en) New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
MY140171A (en) Amino-1,3,5-triazines n-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators
GEP20125537B (en) Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
UY32630A (es) Derivados de 7-aza-espiro[3.5]nonano-7-carboxilatos, su preparación y su aplicación en terapéutica.
TW200510317A (en) Caspase inhibitors and uses thereof
NO20044442L (no) Fosfatprodroger av fluoroksindoler
MX2012006490A (es) Inhibidores azociclicos de hidrolasa de amidas de acidos grasos.
BRPI0410861A (pt) métodos e composições para a produção de aminoácidos
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
PA8573501A1 (es) Derivados de benzoxazina y su empleo
EA200400414A1 (ru) Кристаллические гидраты производных анилида никотиновой кислоты
GT200300095A (es) Derivados de isoquinolina
DK1309562T3 (da) 4-Alkoxycyclohexan-1-aminocarboxylsyreestere og fremgangsmåde til fremstilling deraf
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
MXPA04000511A (es) Derivado de diamina, proceso para producir el mismo, y bactericida que contiene el mismo como ingrediente activo.

Legal Events

Date Code Title Description
FC Refusal